Man Group PLC Inmune Bio, Inc. Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.15 - $11.84 $115,551 - $191,346	-16,161 Reduced 39.86%	24,388 $215,000
Q1 2024 May 15, 2024	BUY	$10.53 - $14.01 $262,144 - $348,778	24,895 Added 159.03%	40,549 $476,000
Q4 2023 Feb 14, 2024	BUY	$6.6 - $11.52 $103,316 - $180,334	15,654 New	15,654 $176,000

5.92M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $82M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.